Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis
Crossref DOI link: https://doi.org/10.1186/s12967-015-0622-x
Published Online: 2015-08-07
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Castañón, Eduardo
Rolfo, Christian
Viñal, David
López, Inés
Fusco, Juan P
Santisteban, Marta
Martin, Patricia
Zubiri, Leire
Echeveste, José I
Gil-Bazo, Ignacio